The potential to rescue CD8 + T-cells from exhaustion has been shown, notably in studies where anti-PD1 therapy was shown to improve the function of exhausted tumor infiltrating CD8+ T cells in ovarian cancer84. This evidence concerns the gene CD8A and neoplasm.